| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Lyell Immunopharma, Inc.
13G/A
LYEL · 55083R203
|
12.3% |
6/18/2026
Event 5/18/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.